Synergy Research Group Joins the European Forum for Good Clinical Practice
“These goals and objectives are very much in line with our own long-term strategies, so we’d be very pleased to join our efforts with EFGCP,” said Igor Stefanov, SynRG General Manager, in a press release.
From the beginning of its membership, SynRG became involved in EFGCP activities and plans on integrating Russia into European R&D community. In December, an EFGCP Board Meeting endorsed a plan to include Russia in the area of EFGCP influence, and, as a result to establish a trustworthy reputation of Russia as a peer ethical partner among the International Clinical Research Community.
“Being a natural member of European family; de-jure as a formal non-member of EU; and de-facto as a terra incognita for most Europeans, Russia suffers from this triple nature, as a result of ignorance, misinterpretation, and lack of trust and rapport from the European community. We are keen to change this situation,” said Igor Stefanov in that same press release.
For more on the collaboration between SynRG and EFGCP, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025